on EUROMEDIS GROUPE (EPA:ALEMG)
Euromedis Laboratories: Adjustment of the liquidity contract
LABORATOIRES EUROMEDIS announces a modification of its liquidity contract. This change is in response to recent regulations, in particular AMF decision no. 2018-01. This decision has been in effect since January 2019. These adjustments aim to ensure compliance with these rules.
In this context, LABORATOIRES EUROMEDIS has entrusted the management of its liquidity contract to the Gilbert Dupont Stock Exchange Company. A withdrawal of 8,000 shares is scheduled for December 13, 2024. Previously, the annual balance sheet as of June 30, 2024 indicated available resources of 22,072 shares.
The cash balance in the liquidity account stood at EUR 65,961.85 as of the same date. This readjustment reflects proactive management in line with current regulatory requirements.
R. H.
Copyright © 2024 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all EUROMEDIS GROUPE news